PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.5100
-0.0100 (-1.92%)
At close: Jun 19, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 88.78 million as of June 18, 2026. Its market cap has increased by 69.24% in one year.
Market Cap
88.78M
Enterprise Value
70.31M
Revenue
24.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 88.78M, an increase of 3,599.24%. That is a compound annual growth rate of 163.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 88.78M | 16.89% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 6.86B |
| Extendicare | 3.21B |
| Green Thumb Industries | 2.35B |
| Sienna Senior Living | 2.32B |
| Helix BioPharma | 108.46M |
| Victory Square Technologies | 74.00M |
| NetraMark Holdings | 73.27M |
| Cannabix Technologies | 72.48M |